title: Thiol-disulfide exchange in peptides derived from human growth hormone during lyophilization and storage in the solid state.
abstract: Lyophilization (freeze-drying) is frequently used to stabilize protein therapeutics. However, covalent modifications such as thiol-disulfide exchange and disulfide scrambling can occur even in the solid state. The effects of lyophilization and storage of lyophilized powders on the mechanism and kinetics of thiol-disulfide exchange have not been elucidated and are explored here. Reaction kinetics was monitored in peptides corresponding to tryptic fragments of human growth hormone (T20 + T20-T21 or T20 + cT20-T21) during different stages of lyophilization and during storage of the lyophilized powders at 22°C and ambient RH. The concentrations of reactants and products were determined using RP-HPLC and product identity confirmed using liquid chromatography-mass spectrometry. Loss of native disulfide was observed for the reaction of T20 with both linear (T20-T21) and cyclic (cT20-T21) peptides during the primary drying step; however, the native disulfides were regenerated during secondary drying with no further change till the end of lyophilization. Deviations from Arrhenius parameters predicted from solution studies and the absence of buffer effects during lyophilization suggest that factors such as temperature, initial peptide concentration, buffer type, and concentration do not influence thiol-disulfide exchange during lyophilization. Results from a "cold finger" method used to study peptide adsorption to ice indicate that there is no preferential adsorption to the ice surface and that its presence may not influence disulfide reactivity during primary drying. Overall, reaction rates and product distribution differ for the reaction of T20 with T20-T21 or cT20-T21 in the solid state and aqueous solution, whereas the mechanism of thiol-disulfide remains unchanged. Increased reactivity of the cyclic peptide in the solid state suggests that peptide cyclization does not offer protection against lyophilization and that damage induced by a process stress further affects storage stability at 22°C and ambient RH.
authors: Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana.
authors: Saradha
authors: S
authors: Chandrasekhar
authors: Elizabeth M
authors: EM
authors: Topp
mesh_terms: D002021:Buffers; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D056148:Chromatography, Reverse-Phase; D004220:Disulfides / Q000737:chemistry*; D004355:Drug Stability; D004356:Drug Storage; D005612:Freeze Drying; D019382:Human Growth Hormone / Q000737:chemistry*; D006801:Humans; D006813:Humidity; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D013058:Mass Spectrometry; D008956:Models, Chemical; D010446:Peptide Fragments / Q000737:chemistry*; D011208:Powders; D055550:Protein Stability; D013438:Sulfhydryl Compounds / Q000737:chemistry*; D013678:Technology, Pharmaceutical / Q000379:methods*; D013696:Temperature
chemical_list: D002021:Buffers; D004220:Disulfides; D010446:Peptide Fragments; D011208:Powders; D013438:Sulfhydryl Compounds; D019382:Human Growth Hormone
keywords: disulfide exchange; freeze-drying; freezing; human growth hormone (hGH); kinetics; lyophilization; peptide; protein
references: Biochemistry. 2000 Oct 17;39(41):12671-7
references: 11027147
references: Biotechnology (N Y). 1994 Mar;12(3):253-6
references: 7764485
references: J Biol Chem. 1977 Jun 10;252(11):3697-702
references: 863899
references: J Pharm Sci. 2014 Apr;103(4):1032-42
references: 24549831
references: Dev Biol Stand. 1992;74:21-37; discussion 37-8
references: 1592171
references: Annu Rev Biochem. 1985;54:237-71
references: 3896121
references: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7222-7
references: 16645035
references: Biochemistry. 1971 Jan 5;10(1):32-8
references: 5538608
references: Pharm Dev Technol. 2007;12(5):505-23
references: 17963151
references: Pharm Res. 1993 May;10(5):687-91
references: 8321832
references: J Pharm Sci. 2009 Sep;98(9):3312-8
references: 18683877
references: Pharm Res. 1994 Jan;11(1):21-9
references: 8140052
references: J Pharm Sci. 2010 Dec;99(12):4849-56
references: 20821392
references: Pharm Res. 2005 Jul;22(7):1176-85
references: 16028019
references: Crit Rev Ther Drug Carrier Syst. 1993;10(4):307-77
references: 8124728
references: Biotechnol Bioeng. 1991 Jan 20;37(2):177-84
references: 18597353
references: Methods Enzymol. 1995;251:8-28
references: 7651233
references: AAPS PharmSci. 2003;5(2):E10
references: 12866937
references: Biochim Biophys Acta. 1998 Oct 14;1388(1):123-32
references: 9774716
references: Mol Pharm. 2012 Apr 2;9(4):718-26
references: 22352965
references: J Pharm Pharmacol. 1994 Mar;46(3):182-5
references: 8027924
references: Chemistry. 2004 Jan 5;10(1):257-66
references: 14695571
references: J Pharm Sci. 1994 Dec;83(12):1662-9
references: 7891292
references: Pharm Res. 1991 Apr;8(4):427-36
references: 1871037
references: Int J Pharm. 2008 Jun 24;358(1-2):108-13
references: 18394830
references: Biotechnology (N Y). 1995 May;13(5):493-6
references: 9634790
references: Nat Biotechnol. 2014 Jan;32(1):32-9
references: 24406926
references: Biotechnol Appl Biochem. 2004 Apr;39(Pt 2):165-77
references: 15032737
references: BMC Pharmacol. 2010;10:6
references: 20529254
references: Int J Pharm. 2000 Apr 25;200(1):1-16
references: 10845681
references: Pharm Res. 2004 Feb;21(2):191-200
references: 15032301
references: Curr Protein Pept Sci. 2009 Dec;10(6):614-25
references: 19538140
references: Growth Horm IGF Res. 2010 Aug;20(4):298-304
references: 20472479
references: Biochemistry (Mosc). 1998 Mar;63(3):357-63
references: 9526132
references: Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13029-33
references: 10557267
references: Int J Pharm. 2005 Jan 31;289(1-2):1-30
references: 15652195
references: Biochem Biophys Res Commun. 2003 Jan 17;300(3):645-8
references: 12507497
references: Biochim Biophys Acta. 1970 Feb 17;200(2):363-9
references: 4984557
references: J Am Chem Soc. 2004 Sep 1;126(34):10508-9
references: 15327286
references: Pharm Res. 1989 Nov;6(11):903-18
references: 2687836